(540) Synergy in Improving the Erectile Responses in a Rat Model of Radical Prostatectomy Between PDE5 Inhibitors and a Topically Applied Nitric Oxide Delivery System
Abstract
Abstract Introduction Our previous work using a rat model of radical prostatectomy (RP) involving bilateral transection of the cavernous nerve (CN) demonstrated that combining orally administered sildenafil with a topically applied nitric oxide–releasing microparticle formulation (NO-MP) significantly improved erectile responses compared to NO-MP alone. Several other phosphodiesterase type 5 inhibitors (PDE5i) are approved for clinical use in erectile dysfunction (ED); although they share the same primary mechanism, PDE5 inhibition, they differ in pharmacokinetics and other properties that could influence their performance in combination therapies. Objective The present study aimed to evaluate whether other FDA-approved PDE5i also act synergistically with topical NO-MP to enhance erectile responses in this RP model. Methods Male Sprague–Dawley rats underwent bilateral CN transection to establish a post-RP model. One week after surgery, animals received oral administration of sildenafil (0.05 mg/kg), tadalafil (0.005 mg/kg), vardenafil (0.01 mg/kg), or avanafil (0.1 mg/kg). Under anesthesia, intracavernosal pressure (ICP) and systemic blood pressure (BP) were continuously recorded via cannulation. Once stable baselines were achieved, 100 mg of NO-MP or control empty microparticles were applied topically to the penile shaft, and erectile responses were monitored. Results Combining oral sildenafil with topical NO-MP led to a significantly faster onset of the first erectile…
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.